Login
← Go Back
Concord Biotech
CONCORDBIO · Pharma > Pharmaceuticals & Drugs Listing date: Aug. 18, 2023
Stock Price vs Company Growth
1d
0.7%
1w
6.9%
1m
6.8%
3m
15.0%
6m
32.8%
1y
40.6%
all
13.1%
🤔 How to analyze this graph?
Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price
₹ 1,255 0.7%
1,225
1,530
Company Overview
Sales
1,125 Cr
Growth: 11.7%
Profit after Tax
324 Cr
Growth: -9.0%
Mid Cap
13,129 Cr
P/E: 40.9x
Industry P/E: 30.2x
Fundamentals
Sales (Cr) ₹ 1,125
Growth 11.7%
EBITDA 39.0%
P/S 11.8x
Dividend 0.6%
P/E 40.9x
Book Value ₹ 184
PEG Ratio 3.4x
ROE 17.6%
P/B 6.7x
Shareholding Pattern
Institutions
Promoters
Others
Increase    Decrease    No change
Company Profile Detailed
The company is an India-based biopharma company and one of the leading global developers and manufacturers of select fermentation-based APIs across Immunosuppressants and oncology.
Belongs to (18 Indices) view more
Followers (1)
varsha96